Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
posted on
Dec 02, 2019 09:19AM
Also remember Biogen went up over $10 billion in MC after a successful Phase 2 for their Alzheimers drug,.... fewer patients and less long than our trial.